Tulisokibart | Interleukin Related interleukin-related.com

Product Name :
Tulisokibart

Search keywords :
Tulisokibart

drugId :
null

Target Vo:
Tumor necrosis factor superfamily member 15

Target Vo Short Name :
TNFSF15

Moa_Name:
Tumor necrosis factor superfamily member 15 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Prometheus Biosciences Inc

Active Company_Name :
Catalent Indiana LLC

Active Indication_Name:
Crohn Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ziltivekimab Biological Activity
Moesin Rabbit mAb MedChemExpress
HMGCR Antibody: HMGCR Antibody is an unconjugated, approximately 97 kDa, rabbit-derived, anti-HMGCR polyclonal antibody. HMGCR Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit background without labeling.

Author: Interleukin Related

Related Posts